Mullennix Stephen 4
4 · UroGen Pharma Ltd. · Filed Feb 4, 2020
Insider Transaction Report
Form 4
Mullennix Stephen
Chief Operating Officer
Transactions
- Award
Stock options (right to buy)
2020-01-31+15,000→ 15,000 totalExercise: $29.41→ Ordinary Shares (15,000 underlying) - Award
Restricted stock unit
2020-01-31+3,000→ 3,000 total→ Ordinary Shares (3,000 underlying)
Footnotes (3)
- [F1]1/3rd of the shares underlying the stock option vest on January 31, 2021 and 1/12th of the shares underlying the stock option vest in 8 quarterly installments thereafter, subject to the Reporting Person's continuous service with the Issuer on each respective vesting date.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
- [F3]1/3rd of the shares underlying the RSU vest on January 31, 2021 and 1/12th of the shares underlying the RSU vest in 8 quarterly installments thereafter, subject to the Reporting Person's continuous service with the Issuer on each respective vesting date.